Company: Merck & Co., Inc.
Ticker: MRK
Form: 10-K
Filed: 2026-02-24
Fiscal Period: {"fp": "FY", "fy": 2025}

Question: What was Merck & Co., Inc.'s net margin in fiscal year 2025?
Question Type: derived_ratio

Concept: NetIncomeLoss
Revenues
Answer (Numeric): 28.08
Answer (Display): 28.08%
Unit: percent

Evidence:
[{"chunk_id": "216", "equivalent_chunk_ids": ["216"], "section": "Consolidated Statement of Income", "supports": ["numerator", "denominator"], "text": "Merck & Co., Inc. and Subsidiaries\nYears Ended December 31\n($ in millions except per share amounts)\nSales\n65,011\n64,168\n60,115\nCosts, Expenses and Other\nCost of sales\n16,382\n15,193\n16,126\nSelling, general and administrative\n10,733\n10,816\n10,504\nResearch and development\n15,789\n17,938\n30,531\nRestructuring costs\nOther (income) expense, net\n43,944\n44,232\n58,226\nIncome Before Taxes\n21,067\n19,936\n1,889\nTaxes on Income\n2,804\n2,803\n1,512\nNet Income\n18,263\n17,133\nLess: Net Income Attributable to Noncontrolling Interests\nNet Income Attributable to Merck & Co., Inc.\n18,254\n17,117\nBasic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders\n7.30\n6.76\n0.14\nEarnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders\n7.28\n6.74\n0.14"}]

Derivation: {"denominator": "revenue", "denominator_value": 65011.0, "format": "percentage", "numerator": "net_income", "numerator_value": 18254.0, "op": "divide"}